Johnson & Johnson Partners With BARDA For COVID-19 Vaccine, Launches Lisa Ling Hosted Series
Written by IMN on 11 Apr 2020
Johnson & Johnson recently announced a lead COVID-19 vaccine candidate plus a landmark partnership with BARDA. Together they commit over $1 billion to an investment to co-fund vaccine research, development & clinical testing.
A commitment by Johnson & Johnson was made to accelerated manufacturing plans as well. The company also introduced “The Road to a Vaccine,” a groundbreaking new series hosted by Lisa Ling.
The series explores the complex process of developing a COVID-19 vaccine and starts on April 14. Learn more here.